Rendić S, Slavica M, Medić-Sarić M (). „Urinary excretion and metabolism of orally administered mefenorex”. European Journal of Drug Metabolism and Pharmacokinetics. 19 (2): 107–17. doi:10.1007/BF03188831. PMID8001591.
Engel J, Kristen G, Schaefer A, von Schlichtegroll A (iunie 1986). „Mefenorex (Rondimen)”. Drug and Alcohol Dependence. 17 (2–3): 229–34. doi:10.1016/0376-8716(86)90010-4. PMID3743406.
drugbank.ca
„Mefenorex”. DrugBank - Canadian Institutes of Health Research. Accesat în .
Vincendeau MJ (). „[A new regulator of appetite: mefenorex]”. Bordeaux Medical (în franceză). 3 (7): 1951–3. PMID5455004.
Beyer G, Huth K, Müller GM, Niemöller H, Raisp I, Vorberg G (februarie 1980). „[The treatment of obesity with the appetite curbing agent Mefenorex]”. Die Medizinische Welt (în germană). 31 (8): 306–9. PMID7374423.
Rendić S, Slavica M, Medić-Sarić M (). „Urinary excretion and metabolism of orally administered mefenorex”. European Journal of Drug Metabolism and Pharmacokinetics. 19 (2): 107–17. doi:10.1007/BF03188831. PMID8001591.
Engel J, Kristen G, Schaefer A, von Schlichtegroll A (iunie 1986). „Mefenorex (Rondimen)”. Drug and Alcohol Dependence. 17 (2–3): 229–34. doi:10.1016/0376-8716(86)90010-4. PMID3743406.